Home LiteratureArticle Details
PMID: 1734285 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Type III restriction enzymes need two inversely oriented recognition sites for DNA cleavage.

Nature ·Vol. 355 ·No. 6359 ·1992-01-30 ·Pages 467-9

Meisel A, Bickle TA, Krüger DH, Schroeder C

Abstract

Type III restriction/modification enzyme recognize short, non-palindromic sequences that can be methylated on only one strand, with the paradoxical consequence that during replication of what is in effect hemimethylated DNA totally unmodified sites arise. Why the unmodified sites are not subject to suicidal restriction was not clear. Here we show that restriction requires two unmodified recognition sites that can be separated by different distances but which must be in inverse orientation. All of the unmodified sites in newly replicated DNA are of course in the same orientation, which explains why they are not restricted. This result may be of relevance to other manifestations of anisotropy in double-stranded DNA, such as genetic imprinting.

MeSH Terms
Base Sequence DNA/metabolism DNA, Circular/metabolism DNA, Viral/metabolism Deoxyribonucleases, Type III Site-Specific/metabolism Kinetics Restriction Mapping Substrate Specificity
Chemicals
DNA, Circular DNA, Viral DNA endodeoxyribonuclease EcoP15I Deoxyribonucleases, Type III Site-Specific
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Meisel A
Institute of Virology, Humboldt University Medical School, Charité, Berlin, Germany.
Bickle T A
Krüger D H
Schroeder C
Article Info
Journal
Nature
Abbr.
Nature
ISSN
0028-0836
Published
1992-01-30
Pages
467-9
Language
English
Region
England
NLM ID
0410462
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]